PHARMACEUTICAL COMPOSITION COMPRISING RACETAM AND CARNITINE AND PROCESS FOR ITS PREPARATION
First Claim
Patent Images
1. A pharmaceutical composition comprising:
- (a) a therapeutically effective quantity of racetam or a pharmaceutically acceptable salt thereof or an isomer thereof;
(b) a therapeutically effective quantity of carnitine or a pharmaceutically acceptable salt thereof or an isomer thereof; and
(c) a pharmaceutically acceptable vehicle.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention refers to a pharmaceutical composition comprising racetam and carnitine. Said pharmaceutical composition may further comprise coenzyme Q10 and/or agent associated with mitochondrial and/or metabolic disturbance, such as hypocholesterolemic agent of the statins group, a hypoglycemic agent, or an antiepileptic agent. The invention also includes a method of treatment for mitochondrial disturbances comprising administration of the pharmaceutical composition of the invention.
9 Citations
75 Claims
-
1. A pharmaceutical composition comprising:
-
(a) a therapeutically effective quantity of racetam or a pharmaceutically acceptable salt thereof or an isomer thereof; (b) a therapeutically effective quantity of carnitine or a pharmaceutically acceptable salt thereof or an isomer thereof; and (c) a pharmaceutically acceptable vehicle. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 75)
-
-
16. A pharmaceutical composition comprising:
-
(a) a therapeutically effective quantity of piracetam, a pharmaceutically acceptable salt thereof, or an isomer thereof; (b) a therapeutically effective quantity of carnitine, a pharmaceutically acceptable salt thereof, or an isomer thereof; and (c) a pharmaceutically acceptable vehicle. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)
-
-
29. A pharmaceutical composition comprising:
-
(a) a therapeutically effective quantity of piracetam, a pharmaceutically acceptable salt thereof, or an isomer thereof; (b) a therapeutically effective quantity of carnitine, a pharmaceutically acceptable salt thereof, or an isomer thereof; (c) a therapeutically effective quantity of coenzyme Q10; and (d) a pharmaceutically acceptable vehicle. - View Dependent Claims (30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)
-
-
41. A pharmaceutical composition comprising:
-
(a) a therapeutically effective quantity of piracetam, a pharmaceutically acceptable salt thereof, or an isomer thereof; (b) a therapeutically effective quantity of carnitine, a pharmaceutically acceptable salt thereof, or an isomer thereof; (c) a therapeutically effective quantity of one or more therapeutic agents associated with mitochondrial and/or metabolic disturbance; and (d) a pharmaceutically acceptable vehicle. - View Dependent Claims (42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)
-
-
53. A pharmaceutical composition comprising:
-
(a) a therapeutically effective quantity of piracetam, a pharmaceutically acceptable salt thereof, or an isomer thereof; (b) a therapeutically effective quantity of carnitine, a pharmaceutically acceptable salt thereof, or an isomer thereof; (c) a therapeutically effective quantity of coenzyme Q10; (d) a therapeutically effective quantity of at least one therapeutic agent associated with mitocondrial and/or metabolic disturbance; and (e) a pharmaceutically acceptable vehicle. - View Dependent Claims (54, 55, 56, 57, 58, 59, 60, 61, 62, 63)
-
- 64. Use of racetam and carnitine, or pharmaceutically acceptable salts thereof, in the manufacture of a medicament for the treatment and/or prevention of a mitochondrial disturbance in a mammal.
-
65. Use of racetam and carnitine, or pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment and/or prevention of mitochondrial disturbance related side effect induced by a drug in a mammal.
- 69. A method of treating and/or preventing mitochondrial disturbances, said method comprising administering to a mammal a combination of racetam and carnitine.
-
74. A method of treating and/or preventing mitochondrial disturbance related side effect induced by a drug, said method comprising administering to a mammal a combination of racetam and carnitine.
Specification